Status:
COMPLETED
Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Understanding how nausea or vomiting caused by chemotherapy effects a patient's treatment decisions may help doctors plan better cancer treatment and may help patients live more comfortably...
Detailed Description
OBJECTIVES: * Determine the contribution of nausea or vomiting to the overall importance for a current state of health in patients with breast or lung cancer undergoing chemotherapy. * Determine the ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of breast cancer or lung cancer
- Must be undergoing chemotherapy with each course lasting 3-6 weeks AND meets all of the following criteria:
- Completed ≥ 1 course with ≥ 1 additional course planned
- At least 2½ weeks since initiation of the most recent course of chemotherapy
- PATIENT CHARACTERISTICS:
- Common Toxicity Criteria performance status 0-2
- Must have command of written and/or spoken English
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
April 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00416689
Start Date
April 1 2000
End Date
January 1 2006
Last Update
June 29 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.